12th Apr 2019 09:42
Cathay International Holdings Limited
("Cathay" or the "Company")
Result of Special General Meeting ("SGM")
Hong Kong, 12 April 2019 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China, today announces that at the SGM held earlier today, the Resolution as set out in the Notice of SGM dated 27 March 2019 was duly passed. The final poll voting result for the Resolution is shown in the table below. In accordance with the UK Listing Rules, only the votes attached to the listed Common Shares were counted for the purposes of voting on the Resolution.
Ordinary resolution | For | Against | Total votes | Withheld |
THAT: The Further Disposal on the terms set out and defined in the Circular is hereby approved, and the Board or any duly authorised committee thereof is authorised to: (i) make or agree any amendment, variation, waiver or extension to the terms of the Further Disposal, which is not material; and (ii) do all such other things as the Board or such committee may consider necessary or desirable in connection with the Further Disposal (provided that such other things have no material impact on the terms of the Further Disposal), in each case which the Board or such committee considers reasonable and in the best interests of Shareholders as a whole. | 272,722,215 | 3,321 | 272,725,536 | 3,088 |
Notes:
1. Any proxy votes which are at the discretion of the Chairman have been included in the 'For' total.
2. A vote 'Withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the resolution.
A copy of the resolution passed at the meeting is being uploaded today to the National Storage Mechanism and will shortly be available for viewing at www.morningstar.com.
The final voting result for the resolution will also be displayed on the Company website at www.cathay-intl.com.hk
- ENDS -
For further enquiries, please contact:
Cathay International Holdings Limited Eric Siu (Finance Director) Patrick Sung (Director and Controller)
|
Tel: +852 2828 9289 |
Consilium Strategic Communications Mary-Jane Elliott / Matthew Neal / Lindsey Neville
|
Tel: +44 (0) 203 709 5702
|
About Cathay
Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on investment opportunities in the growing domestic demand for high quality healthcare products in the PRC and build portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a track record of identifying investment opportunities in this area including: Lansen, a PRC specialty pharmaceutical company focused on rheumatology and dermatology; Haizi, a PRC inositol manufacturer; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.
The Group employs approximately 1,800 people across the PRC, including over 20 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment in Shenzhen. For more information please visit the Company's website: http://www.cathay-intl.com.hk
Related Shares:
CTI.L